Enhancement of learning behaviour by a potent nitric oxide-guanylate cyclase activator YC-1
Article first published online: 8 APR 2005
DOI: 10.1111/j.1460-9568.2005.03993.x
Additional Information
How to Cite
Chien, W.-L., Liang, K.-C., Teng, C.-M., Kuo, S.-C., Lee, F.-Y. and Fu, W.-M. (2005), Enhancement of learning behaviour by a potent nitric oxide-guanylate cyclase activator YC-1. European Journal of Neuroscience, 21: 1679–1688. doi: 10.1111/j.1460-9568.2005.03993.x
Publication History
- Issue published online: 12 APR 2005
- Article first published online: 8 APR 2005
- Received 14 April 2004, revised 3 December 2004, accepted 23 December 2004
- Abstract
- Article
- References
- Cited By
Keywords:
- cGMP;
- learning;
- long-term potentiation;
- memory;
- NO;
- PKG;
- YC-1
Abstract
Memory is one of the most fundamental mental processes, and various approaches have been used to understand the mechanisms underlying this process. Nitric oxide (NO), cGMP and protein kinase G (PKG) are involved in the modulation of synaptic plasticity in various brain regions. YC-1, which is a benzylindazole derivative, greatly potentiated the response of soluble guanylate cyclase to NO (up to several hundreds fold). We have previously shown that YC-1 markedly enhances long-term potentiation in hippocampal and amygdala slices via NO-cGMP-PKG-dependent pathway. We here further investigated whether YC-1 promotes learning behaviour in Morris water maze and avoidance tests. It was found that YC-1 shortened the escape latency in the task of water maze, increased and decreased the retention scores in passive and active avoidance task, respectively. Administration of YC-1 30 min after foot-shock stimulation did not significantly affect retention scores in response to passive avoidance test. Administration of scopolamine, a muscarinic antagonist, markedly impaired the memory acquisition. Pretreatment of YC-1 inhibited the scopolamine-induced learning deficit. The enhancement of learning behaviour by YC-1 was antagonized by intracerebroventricular injection of NOS inhibitor L-NAME and PKG inhibitors of KT5823 and Rp-8-Br-PET-cGMPS, indicating that NO-cGMP-PKG pathway is also involved in the learning enhancement action of YC-1. YC-1 is thus a good drug candidate for the improvement of learning and memory.

1460-9568/asset/EJN_left.gif?v=1&s=3d5223e01f3255a775e3d3fc8d54bc1c38677c6c)
